文献速递妇科产科

GOG 244:妇科癌症淋巴水肿问卷与下肢淋巴水肿的关联

GOG 244 - The LymphEdema and Gynecologic cancer (LEG) study: The association between the gynecologic cancer lymphedema questionnaire (GCLQ) and lymphedema of the lower extremity (LLE).
PubMed 文献 · Gynecol Oncol · 2019-10-31

在GOG 244研究中,987例可评估的子宫内膜癌、宫颈癌或外阴癌根治性手术(含淋巴结清扫)患者完成基线和至少一次术后GCLQ及肢体体积变化评估。14%的患者自报下肢淋巴水肿诊断,GCLQ总分较基线增加≥4分的患者中自报诊断者显著更多(p<0.001),且肢体体积变化>10%与自报一般性肿胀、沉重感、感染相关症状和躯体功能显著相关。

要点

  • GCLQ总分较基线增加≥4分与患者自报下肢淋巴水肿诊断显著相关(p<0.001)。
  • 肢体体积变化>10%与自报一般性肿胀、沉重感、感染相关症状和躯体功能显著相关(p值分别为<0.001、0.005、0.002、0.006)。
  • GCLQ联合肢体体积变化可能提高识别下肢淋巴水肿的能力。

核心结论

  • 患者自报症状(采用GCLQ测量)能区分有无患者自报下肢淋巴水肿诊断,并显示出预测价值。
  • GCLQ联合肢体体积变化可能增强识别下肢淋巴水肿的能力。

研究设计与样本

  • GOG 244研究,纳入因子宫内膜癌、宫颈癌或外阴癌行根治性手术(含淋巴结清扫)的患者。
  • 患者完成基线和至少一次术后GCLQ及肢体体积变化评估;987例合格患者中894例可评估(子宫内膜癌719例、宫颈癌136例、外阴癌39例)。
  • 采用线性混合模型分析症状簇评分和GCLQ总分变化,并校正疾病部位和评估时间。

主要发现

  • 894例可评估患者中14%自报下肢淋巴水肿诊断(子宫内膜癌11%、宫颈癌18%、外阴癌38%)。
  • 自报下肢淋巴水肿诊断者较未诊断者中GCLQ总分较基线增加≥4分的患者显著更多(p<0.001)。
  • 自报下肢淋巴水肿诊断者所有GCLQ症状簇评分较基线的变化均显著大于未诊断者。
  • 肢体体积变化>10%与自报一般性肿胀(p<0.001)、沉重感(p=0.005)、感染相关症状(p=0.002)和躯体功能(p=0.006)显著相关。

关键数值与推荐

  • GCLQ为20条目问卷,测量7个症状簇:疼痛、沉重感、感染相关、麻木、躯体功能、一般性肿胀和肢体肿胀。
  • 下肢淋巴水肿定义为GCLQ上患者自报的淋巴水肿诊断。
  • 肢体体积变化通过基于周径测量的体积计算得出。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To explore whether patient-reported lymphedema-related symptoms, as measured by the Gynecologic Cancer Lymphedema Questionnaire (GCLQ), are associated with a patient-reported diagnosis of lymphedema of the lower extremity (LLE) and limb volume change (LVC) in patients who have undergone radical surgery, including lymphadenectomy, for endometrial, cervical, or vulvar cancer on Gynecologic Oncology Group (GOG) study 244. METHODS: Patients completed the baseline and at least one post-surgery GCLQ and LVC assessment. The 20-item GCLQ measures seven symptom clusters-aching, heaviness, infection-related, numbness, physical functioning, general swelling, and limb swelling. LLE was defined as a patient self-reported LLE diagnosis on the GCLQ. LVC was measured by volume calculations based on circumferential measurements. A linear mixed model was fitted for change in symptom cluster scores and GCLQ total score and adjusted for disease sites and assessment time. RESULTS: Of 987 eligible patients, 894 were evaluable (endometrial, 719; cervical, 136; vulvar, 39). Of these, 14% reported an LLE diagnosis (endometrial, 11%; cervical, 18%; vulvar, 38%). Significantly more patients diagnosed versus not diagnosed with LLE reported ≥4-point increase from baseline on the GCLQ total score (p < 0.001). Changes from baseline were significantly larger on all GCLQ symptom cluster scores in patients with LLE compared to those without LLE. An LVC increment of >10% was significantly associated with reported general swelling (p < 0.001), heaviness (p = 0.005), infection-related symptoms (p = 0.002), and physical function (p = 0.006). CONCLUSIONS: Patient-reported symptoms, as measured by the GCLQ, discerned those with and without a patient-reported LLE diagnosis and demonstrated predictive value. The GCLQ combined with LVC may enhance our ability to identify LLE.

来源:Gynecol Oncol,查看原文。版权归原作者所有。

引用

  1. Carter J, Huang HQ, Armer J, et al. GOG 244 - The LymphEdema and Gynecologic cancer (LEG) study: The association between the gynecologic cancer lymphedema questionnaire (GCLQ) and lymphedema of the lower extremity (LLE). Gynecol Oncol. 2019. PMID: 31679787. doi:10.1016/j.ygyno.2019.09.027

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。